How Levonorgestrel Works: Emergency Contraception and IUDs

Levonorgestrel is a synthetic progestin used in more contraceptive products than any other hormone of its class, from emergency pills to intrauterine devices to subdermal implants. It mimics the activity of the body’s natural progesterone but is far more potent, and its effects differ depending on how it enters the body and in what dose. Most people encounter the name on a box of emergency contraception, but levonorgestrel’s medical uses extend well beyond the morning-after pill, and the science behind it holds some surprises about who it works best for, what it does not do, and where the evidence is still catching up to common assumptions.

How Levonorgestrel Prevents Pregnancy

When taken as emergency contraception, levonorgestrel works primarily by delaying or blocking ovulation. A single 1.5 mg dose interferes with the hormonal surge that triggers the release of an egg from the ovary.¹ This is an important distinction because a persistent myth holds that emergency contraception works by preventing a fertilized egg from implanting in the uterus. The available human data point in the opposite direction: levonorgestrel’s contraceptive effect comes from disrupting ovulation, not from blocking implantation.²

In lower daily doses, such as those released by an intrauterine device or implant, levonorgestrel thickens cervical mucus so sperm have a harder time reaching an egg, thins the uterine lining, and in some users suppresses ovulation partially or completely. The exact balance of these effects depends on the dose and the delivery method.

Why Timing Matters So Much for the Morning-After Pill

The fact that levonorgestrel works by blocking ovulation also means its effectiveness is tightly linked to where you are in your cycle when you take it. A study that tracked whether women took levonorgestrel emergency contraception before or after ovulation found striking results: among women who took it before ovulation, none became pregnant out of the 16 pregnancies that would have been expected. Among women who took it on the day of ovulation or after, pregnancies occurred at the same rate you would predict without any intervention at all.³ An earlier pilot study reached the same conclusion: levonorgestrel emergency contraception is highly effective before ovulation and has little or no effect on events after ovulation has already occurred.⁴

This has practical implications. The standard advice to take levonorgestrel as soon as possible after unprotected sex is sound, but the reasoning is about ovulation timing, not about the pill “wearing off” as hours pass. If you have already ovulated, taking it sooner will not help because the mechanism no longer applies. Since most people cannot pinpoint their exact ovulation day, the general urgency advice remains the safest bet.

Body Weight and Reduced Effectiveness

One of the most significant real-world limitations of levonorgestrel emergency contraception is that it appears to work less well in heavier individuals. A pooled analysis found that women who became pregnant despite taking levonorgestrel had a significantly higher average body weight and BMI than those who did not. The estimated pregnancy rate climbed from about 1.4% among women weighing 65 to 75 kg to roughly 6% among women above 80 kg.⁵

The pharmacokinetic explanation lines up with the clinical data. Studies comparing blood levels of levonorgestrel after a standard emergency dose found that peak concentration and total drug exposure were roughly half as high in women with an obese BMI compared to women with a normal BMI.⁶ A separate pharmacokinetic study confirmed that extremely obese women were exposed to lower levels of both total and bioavailable levonorgestrel, suggesting that lower circulating drug levels may explain the reduced efficacy.⁷

This does not mean levonorgestrel emergency contraception is useless for heavier people. It still reduces the chance of pregnancy compared to doing nothing. But the drop in effectiveness is steep enough that some guidelines suggest ulipristal acetate (a different emergency contraceptive) or a copper IUD as alternatives that may be more reliable at higher body weights.

Drug Interactions That Can Undermine Effectiveness

Levonorgestrel is broken down in the liver by a group of enzymes, and certain medications speed up that breakdown dramatically. The classic example is rifampin, an antibiotic used for tuberculosis: modeling studies estimate that co-administering rifampin cuts levonorgestrel exposure roughly in half.⁸ Efavirenz, an antiretroviral drug used in HIV treatment, has a similar effect: simulated levonorgestrel blood levels were about 50% lower in virtual patients taking efavirenz alongside a levonorgestrel implant.⁹

Not all forms of levonorgestrel are equally vulnerable to these interactions, though. A large adverse-event analysis found that failure reports were significantly higher for oral levonorgestrel products and implants when used alongside enzyme-inducing drugs, but the levonorgestrel IUD showed no increase in failure reports.¹⁰ The likely reason is that the IUD delivers levonorgestrel directly to the uterus, so the drug acts locally rather than needing to survive a trip through the liver first. If you take a medication known to speed up liver enzymes, this is worth discussing with a prescriber when choosing a contraceptive method.

The Levonorgestrel IUD for Heavy Menstrual Bleeding

Beyond contraception, the levonorgestrel-releasing intrauterine device (often known by brand names like Mirena) has become a first-line treatment for heavy menstrual bleeding. By releasing a small, steady dose of hormone directly into the uterus, the IUD thins the uterine lining and dramatically reduces blood loss without the systemic side effects of oral hormones.

The numbers are striking. In a clinical study evaluating a 52 mg levonorgestrel IUD, the median reduction in blood loss was about 93% by the third menstrual cycle and nearly 98% by the sixth cycle. By that point, roughly one in five participants had no bleeding or spotting at all, and another three in ten had only spotting.¹¹ Another study tracking longer-term outcomes found that hemoglobin levels rose substantially after IUD placement, reflecting the reduction in chronic blood loss.¹² For many women, the levonorgestrel IUD has replaced what would otherwise be a surgical procedure like endometrial ablation or hysterectomy.

Androgenic Properties and Why They Matter

Not all progestins behave the same way in the body. Levonorgestrel is derived from a testosterone-like chemical backbone, and it retains some androgenic activity, meaning it can weakly stimulate the same receptors that testosterone uses. Binding studies show that levonorgestrel’s affinity for androgen receptors is modest but measurable, roughly one-fifth the binding strength of the body’s most potent androgen.¹³

In practice, this androgenic lean can affect sex hormone binding globulin (SHBG), a protein that mops up free testosterone in the blood. Levonorgestrel tends to lower SHBG levels, which can leave slightly more free testosterone circulating.¹⁴ For most users this is clinically insignificant, but for people already prone to acne or unwanted hair growth, levonorgestrel-containing pills can occasionally worsen those symptoms compared to pills containing newer, less androgenic progestins. This is also why dermatologists sometimes prefer prescribing oral contraceptives with drospirenone or norgestimate over levonorgestrel for patients seeking both contraception and skin improvement.

Venous Blood Clot Risk Compared to Other Progestins

Combined oral contraceptives (those containing both estrogen and a progestin) carry a small but real risk of venous blood clots. The risk varies depending on which progestin is in the pill, and levonorgestrel has consistently been the benchmark for the lowest clot risk among commonly used progestins. A systematic review and meta-analysis found that pills containing desogestrel, drospirenone, gestodene, or cyproterone acetate all carried a higher relative risk of blood clots compared to levonorgestrel-containing pills, with pooled estimates ranging from about 1.3 to 2.0 times higher.¹⁵ A separate meta-analysis confirmed this hierarchy, finding that desogestrel combined with standard-dose estrogen showed the highest relative risk compared to levonorgestrel as the reference.¹⁶

This is one of the reasons levonorgestrel remains so widely prescribed despite being one of the older progestins on the market. Newer progestins offer some advantages for skin and androgenic side effects, but none has beaten levonorgestrel’s clot safety profile in combination pills. For people with clot risk factors like a family history or a recent long-haul flight habit, this difference can meaningfully influence which pill a clinician recommends.

Mood and Depression

Whether hormonal contraception affects mood is one of the most debated topics in reproductive health. The relationship is real but complex: hormonal contraception is known to trigger or worsen depression in some users, and the progestin component appears to be the primary driver.¹⁷ What makes levonorgestrel interesting in this context is that data from the IUD form suggest the dose matters.

A nationwide cohort study of nulliparous women in Denmark compared depression rates across different levonorgestrel IUDs. The high-dose 52 mg IUD was associated with roughly 31 depression diagnoses per 1,000 person-years. The lower-dose 19.5 mg and 13.5 mg IUDs showed lower rates, and the estimated reduction compared to the high-dose device was about 11 to 13 fewer depressions per 1,000 person-years.¹⁸ The reduction persisted over the approved duration of use, although it shrank somewhat with time. This is not proof that levonorgestrel causes depression, since observational studies cannot fully rule out other explanations, but the dose-response pattern is suggestive. If you have a history of mood sensitivity to hormones, the lower-dose IUD options may be worth considering.

Stroke and Cardiovascular Signals

A recent prospective cohort study found that the progestin-only intrauterine device was not associated with an increased risk of ischemic stroke or heart attack, with the high-dose 52 mg levonorgestrel IUD making up nearly 90% of the hormonal IUD use tracked.¹⁹ A separate study went further, reporting that levonorgestrel IUD use was associated with a 22% lower rate of ischemic stroke, raising the question of whether levonorgestrel might have some protective vascular effect.²⁰ These are observational findings and could reflect healthier-user bias (people who get IUDs may differ from those who do not in ways that affect stroke risk). Still, the consistent absence of cardiovascular harm is reassuring, especially compared to combined oral contraceptives, which are known to modestly raise stroke risk through the estrogen component.

Subdermal Implants

Levonorgestrel also comes in a two-rod subdermal implant form (known as Jadelle, or the biosimilar Sino-implant II). These are placed just under the skin of the upper arm and release levonorgestrel continuously for years. The rods start with a burst of drug release that tapers over time following a predictable curve. After three years, both Jadelle and Sino-implant (II) have released roughly 30% of their total levonorgestrel load, and their release profiles are similar enough to be considered comparable.²¹ Estimated daily release after three years sits around 24 to 29 micrograms per day depending on the product.²²

Because implants deliver drug systemically through the bloodstream rather than locally to the uterus, they share some of the same vulnerabilities as oral forms when it comes to drug interactions, as noted earlier. They also tend to cause irregular bleeding patterns, which is one of the most common reasons people have them removed before the intended duration.

Fertility After Stopping

A common concern is whether long-term levonorgestrel use, especially the IUD form that thins the uterine lining, might delay the return of fertility. The evidence is reassuring. In a study comparing women who had a levonorgestrel IUD removed with those who had a copper IUD removed, the cumulative conception rate after 12 months was about 79% for the levonorgestrel group and 71% for the copper group, a difference that was not statistically significant. Nearly all pregnancies in both groups occurred within the first year, and the researchers concluded that the endometrium recovers quickly after levonorgestrel IUD removal.²³

Endometriosis and Pelvic Pain

The levonorgestrel IUD is frequently used off-label to manage pain from endometriosis. A systematic review of studies found that all assessed trials reported improvement in pelvic pain, painful periods, and menstrual bleeding with the device.²⁴ One randomized trial found the IUD comparable to a GnRH analogue (a drug that suppresses ovarian function) for reducing chronic pelvic pain associated with endometriosis, with no significant difference between the two treatments over six months.²⁵

That said, a Cochrane review specifically examining the IUD’s use after endometriosis surgery was far less enthusiastic. The reviewers concluded that there was no high-quality evidence to support the widespread practice of placing a levonorgestrel IUD after surgical treatment for endometriosis, noting that the available trials were small and the certainty of the evidence was low to very low.²⁶ The device may well help, but the formal evidence base has not caught up to clinical practice.

The Levonorgestrel IUD in Menopause

For perimenopausal and menopausal women who use estrogen replacement therapy, a progestin must be added to protect the uterine lining from overgrowth that estrogen alone can cause. The levonorgestrel IUD can serve as that progestin source. Studies have found it equally effective as oral or vaginal progesterone for preventing endometrial hyperplasia.²⁷ A five-year study found that intrauterine progestin delivery effectively opposed estrogen’s effects on the endometrium and induced amenorrhea in most users.²⁸ The appeal of this approach is that it concentrates the progestin where it is needed (the uterus) while minimizing systemic progestin exposure, which some clinicians believe reduces side effects like bloating and mood changes.

Ectopic Pregnancy Concerns

Periodic claims surface that levonorgestrel emergency contraception increases the risk of ectopic pregnancy, where a fertilized egg implants outside the uterus. The picture here is messy. A case-control study from Kenya found an elevated odds of ectopic pregnancy among levonorgestrel emergency contraception users.²⁹ But a larger multicenter case-control study found no increased risk of ectopic pregnancy with previous levonorgestrel emergency contraception use, with one important caveat: women who had unprotected intercourse after taking the pill, or who used it repeatedly in the same cycle, did have a higher risk.³⁰

The interpretation that best fits the mechanism is that levonorgestrel does not cause ectopic pregnancies directly. When it prevents pregnancy altogether (by blocking ovulation), no ectopic can occur. But when it fails to prevent pregnancy, perhaps because it was taken too late in the cycle, the proportional share of pregnancies that happen to be ectopic may look higher simply because the drug selectively prevented the intrauterine ones. Repeat use within the same cycle and continued unprotected sex after the emergency dose both increase the chance of a breakthrough pregnancy, which could explain the signal seen in some studies.

Environmental Footprint in Waterways

Levonorgestrel that passes through the body ends up in wastewater, and enough of it survives treatment to show up in surface water at biologically active concentrations. A review of the environmental literature found that levonorgestrel poses an environmental risk to surface water, with multiple studies documenting negative effects on the reproduction and growth of aquatic organisms.³¹

The effects can be dramatic. In zebrafish, exposure to levonorgestrel at concentrations found in real waterways caused complete sex reversal, producing 100% male populations at the tested levels.³² In fathead minnows, another commonly studied freshwater fish, levonorgestrel exposure reduced larval survival and growth and disrupted hormone production at concentrations in the tens of nanograms per liter.³³ These findings reflect levonorgestrel’s androgenic activity, the same property that can cause mild androgenic side effects in human users. In fish, the consequences are more extreme because their sexual development is exquisitely sensitive to hormonal signals in the water. Whether current environmental concentrations are high enough to shift wild fish populations is still being studied, but the laboratory evidence has made levonorgestrel one of the emerging contaminants that aquatic toxicologists watch closely.

Irregular Bleeding and Why It Happens

The most common complaint across all progestin-only contraceptive methods, levonorgestrel included, is unpredictable bleeding. This can take the form of spotting between periods, lighter but more frequent bleeding, or prolonged episodes. The underlying mechanism is not fully understood, though several pathways have been proposed involving changes to blood vessel structure in the uterine lining and altered local immune responses.³⁴ Irregular bleeding tends to be most pronounced in the first few months and often improves over time, particularly with the IUD, where many users eventually experience very light periods or none at all. The irony is that the same drug that causes irregular bleeding in the short term is one of the most effective treatments for heavy menstrual bleeding in the long term.

For someone considering a levonorgestrel method and worried about unpredictable bleeding, knowing that the pattern typically settles can help with the decision to stick with the method through the adjustment period. Many discontinuations happen in those early months, often right before bleeding would have improved. There is no reliable way to predict whose bleeding will settle quickly and whose will linger, which remains one of the frustrating gaps in what the science can tell us ahead of time.